Long-acting somatostatin analogue
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Long-acting somatostatin analogue, covering 2025-03-03 to 2025-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial [Phase 2, Phase 3]